ENTITY
Roche Holding

Roche Holding (ROG SW)

80
Analysis
Health CareUnited States
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. Roche Holding serves customers worldwide.
more
bullishRoche Holding
21 Nov 2024 11:04Podcast

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges

The CEO of Roche, a leading healthcare company, discusses their role in driving innovation and advancements in cancer treatment, personalized...

17 Nov 2024 09:29

Who Are Leading the Charge in the RNAissance of Medicine

RNA therapeutics: We analyze the field and spotlight top players driving this precision medicine, for tackling rare diseases with innovative solutions

Logo
235 Views
Share
bullishMorphoSys AG
07 Feb 2024 07:54

Novartis Strikes for Possible Myelofibrosis Blockbuster

​Novartis offers premium for MorphoSys AG in a bet on pelabrisib as a potential blockbuster for myelofibrosis treatment. Shareholders are likely to...

Share
18 Dec 2023 06:44

Liquid Universe of European Ordinary and Preferred Shares: December‘23 Report

Since mid-November, spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have tightened, 10...

Share
12 Feb 2022 23:40

Insights from Data Mining Technical Publications - Microbes - Bacteriophages

Innovations are modifying and harnessing microbes for new  uses in agriculture, industry, and as potential new therapeutics to replace or...

Logo
283 Views
Share
x